Drug Trial Radar · NCT04970836
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
Last checked: Nov 20, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Aug 1, 2021
Primary completion
Dec 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- National Taiwan University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Academia Sinica, Taiwan; Ministry of Science and Technology, Taiwan
- First posted
- Jul 21, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years, up to 36 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This prospective cohort study aims to provide the evidence-based clinical guide to help decide the revaccination doses of hepatitis B vaccine that the high-risk young adults without hepatitis B seroprotective antibodies (anti-HBs titer\<10 mIU/mL) need to take.
Conditions
- Hepatitis B
- Vaccination; Infection
- Preventable Disease, Vaccine
Interventions
recombinant hepatitis B vaccineBiological
Hepatitis B vaccine (Engerix-B) will be administered to the eligible participants by 4 groups. Each case will be tracked for 12 months, at 0, 7-10 days, 28 days, 24-28 weeks, 48-52 weeks anti-HBs titer concentration and 4 follow-up questionnaires.
Primary outcomes
What the sponsor says the trial is designed to measure.
- anti-HBs titer response rate at 7-10 daysTime frame: 7-10 days
- anti-HBs titer response rate at one monthTime frame: 28 days
- anti-HBs titer response rate at 6 monthsTime frame: 24-28 weeks
- anti-HBs titer response rate at 12 monthsTime frame: 48-52 weeks
- anti-HBs titer immune response change at 12 monthsTime frame: 48-52 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Family Medicine, NTUH
Taipei, Taipei, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.